<DOC>
	<DOCNO>NCT01247142</DOCNO>
	<brief_summary>The purpose study evaluate diagnostic potential biomarkers invasive pulmonary aspergillosis exhale breath condensate .</brief_summary>
	<brief_title>Evaluation Exhaled Breath Condensate Diagnosis Invasive Pulmonary Aspergillosis</brief_title>
	<detailed_description>Invasive pulmonary aspergillosis ( IPA ) life-threatening infection immunocompromised patient . The poor prognosis disease partly attribute difficulty encounter diagnosis infection . Invasive sampling procedure often preclude patient . In addition , conventional diagnostic technique lack sensitivity . Recently increase interest investigation lung noninvasive mean include measurement biomarkers exhale breath ( e.g . NO ) find cool condensed exhalate , term EBC . It demonstrate measurable fraction EBC healthy subject derive aerosolized airway line fluid . The presence biomarkers IPA investigate EBC patient IPA , compare control .</detailed_description>
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Invasive Pulmonary Aspergillosis</mesh_term>
	<mesh_term>Pulmonary Aspergillosis</mesh_term>
	<criteria>hospitalisation hematology intensive care department age &gt; 16 year informed consent proven probable IPA ( EORTC/ MSG criterion ) galactomannan positivity BAL serum age &lt; 16 year</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>invasive pulmonary aspergillosis</keyword>
	<keyword>exhale breath condensate</keyword>
</DOC>